EcoR1 Capital, LLC, 10% Owner at iTeos Therapeutics, Inc. (ITOS), bought 6,617,956 shares at $8.00 ($51.0M) on 2025-05-15, disclosed to the SEC on 2025-05-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.41 | 1,658,978 | $12.3M | 24.1% |
| 2 | $7.41 | 1,658,978 | $12.3M | 24.1% |
| 3 | $8.00 | 3,300,000 | $26.4M | 51.8% |
| Total | $7.70 avg | 6,617,956 | $51.0M | 100% |
| Filing → |
| AKTS | BUY | 2026-01-12 | $40.0M | — | Filing → |
| ADAP | SELL | 2025-07-30 | $13.2M | — | Filing → |
| ZYME | BUY | 2025-05-19 | $1.3M | — | Filing → |